Compositions and methods for treatment of thyroid eye disease
US12404335B2 · kind B2 · utility
0Cited by
43References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2023 |
| Grant date | Sep 2, 2025 |
| Priority date | — |
| Expiry date | Dec 31, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies and compositions against Insulin-Like Growth Factor-1 Receptor (IGF-1R) and uses thereof for treating thyroid eye disease (TED) are provided herein. Anti-IGF-1R antibodies and compositions described herein can be used in methods of treating or reducing the severity of thyroid eye disease (TED) in subjects in need thereof, by inhibiting the activity of IGF-1R with such antibodies and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.